BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 36077242)

  • 1. A Review of Signaling Transduction Mechanisms in Osteoclastogenesis Regulation by Autophagy, Inflammation, and Immunity.
    Tong X; Yu G; Fu X; Song R; Gu J; Liu Z
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminothiazoles inhibit osteoclastogenesis and PGE
    Kats A; Gerasimcik N; Näreoja T; Nederberg J; Grenlöv S; Lagnöhed E; Desai S; Andersson G; Yucel-Lindberg T
    J Cell Mol Med; 2019 Feb; 23(2):1152-1163. PubMed ID: 30506812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine-mediated immunomodulation of osteoclastogenesis.
    Zhou P; Zheng T; Zhao B
    Bone; 2022 Nov; 164():116540. PubMed ID: 36031187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of osteoclast-mediated bone resorption by microRNA.
    Ji L; Li X; He S; Chen S
    Cell Mol Life Sci; 2022 May; 79(6):287. PubMed ID: 35536437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HSC70 mediated autophagic degradation of oxidized PRL2 is responsible for osteoclastogenesis and inflammatory bone destruction.
    Li Q; Yue T; Du X; Tang Z; Cui J; Wang W; Xia W; Ren B; Kan S; Li C; Wu C; Niu X; Li B; Lin K; Luo J; Chen G; Wang Z
    Cell Death Differ; 2023 Mar; 30(3):647-659. PubMed ID: 36182990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells-derived interferon-λ1 ameliorated inflammatory bone destruction through inhibiting osteoclastogenesis.
    Chen Y; Wang Y; Tang R; Yang J; Dou C; Dong Y; Sun D; Zhang C; Zhang L; Tang Y; Dai Q; Luo F; Xu J; Dong S
    Cell Death Dis; 2020 Jun; 11(6):414. PubMed ID: 32488049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin‑17A facilitates osteoclast differentiation and bone resorption via activation of autophagy in mouse bone marrow macrophages.
    Song L; Tan J; Wang Z; Ding P; Tang Q; Xia M; Wei Y; Chen L
    Mol Med Rep; 2019 Jun; 19(6):4743-4752. PubMed ID: 31059030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-Specific PTP1B Deficiency Attenuates Inflammation-Induced and Ovariectomy-Induced Bone Loss in Mice by Inhibiting Osteoclastogenesis.
    Kim HJ; Ryu KY; Kim YG; Kim MO; Lee JH; Song MK; Youn YJ; Pokhrel NK; Kim SH; Kim JY; Jung HJ; Kim WS; Hong CW; Kim HH; Lee Y
    J Bone Miner Res; 2022 Mar; 37(3):505-514. PubMed ID: 34812548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-17 promotes osteoclastogenesis and periodontal damage via autophagy in vitro and in vivo.
    Zhong J; Wang Z; Yuan W; Shen Y; Chen L
    Int Immunopharmacol; 2022 Jun; 107():108631. PubMed ID: 35219162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Afamin stimulates osteoclastogenesis and bone resorption via Gi-coupled receptor and Ca2+/calmodulin-dependent protein kinase (CaMK) pathways.
    Kim BJ; Lee YS; Lee SY; Park SY; Dieplinger H; Yea K; Lee SH; Koh JM; Kim GS
    J Endocrinol Invest; 2013 Nov; 36(10):876-82. PubMed ID: 23698732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of TAK1 in RANKL-Induced Osteoclastogenesis.
    Jianwei W; Ye T; Hongwei W; Dachuan L; Fei Z; Jianyuan J; Hongli W
    Calcif Tissue Int; 2022 Jul; 111(1):1-12. PubMed ID: 35286417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy-linked FYVE containing protein WDFY3 interacts with TRAF6 and modulates RANKL-induced osteoclastogenesis.
    Wu DJ; Gu R; Sarin R; Zavodovskaya R; Chen CP; Christiansen BA; Zarbalis KS; Adamopoulos IE
    J Autoimmun; 2016 Sep; 73():73-84. PubMed ID: 27330028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flunarizine inhibits osteoclastogenesis by regulating calcium signaling and promotes osteogenesis.
    Kim HJ; Lee J; Lee GR; Kim N; Lee HI; Kwon M; Kim NY; Park JH; Kang YH; Song HJ; Kim T; Shin DM; Jeong W
    J Cell Physiol; 2021 Dec; 236(12):8239-8252. PubMed ID: 34192358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fungal metabolite (+)-terrein abrogates osteoclast differentiation via suppression of the RANKL signaling pathway through NFATc1.
    Nakagawa S; Omori K; Nakayama M; Mandai H; Yamamoto S; Kobayashi H; Sako H; Sakaida K; Yoshimura H; Ishii S; Ibaragi S; Hirai K; Yamashiro K; Yamamoto T; Suga S; Takashiba S
    Int Immunopharmacol; 2020 Jun; 83():106429. PubMed ID: 32222639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tereticornate A suppresses RANKL-induced osteoclastogenesis via the downregulation of c-Src and TRAF6 and the inhibition of RANK signaling pathways.
    Liu T; Jiang L; Xiang Z; Li J; Zhang Y; Xiang T; Wang W; Li X; Jia Y; Huang X; Lu X; Xu H; Wang X; Sheng J
    Biomed Pharmacother; 2022 Jul; 151():113140. PubMed ID: 35605290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trehalose reduces bone loss in experimental biliary cirrhosis rats via ERK phosphorylation regulation by enhancing autophagosome formation.
    Xu X; Wang R; Wu R; Yan W; Shi T; Jiang Q; Shi D
    FASEB J; 2020 Jun; 34(6):8402-8415. PubMed ID: 32367591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 transiently promotes proliferation of osteoclast precursors and stimulates the production of inflammatory mediators.
    Chang PY; Wu HK; Chen YH; Hsu YP; Cheng MT; Yu CH; Chen SK
    Mol Biol Rep; 2022 May; 49(5):3927-3937. PubMed ID: 35218446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Osteoclastogenesis and Bone Resorption in vitro and in vivo by a prenylflavonoid xanthohumol from hops.
    Li J; Zeng L; Xie J; Yue Z; Deng H; Ma X; Zheng C; Wu X; Luo J; Liu M
    Sci Rep; 2015 Dec; 5():17605. PubMed ID: 26620037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous Immunoglobulin (IVIG) Attenuates TNF-Induced Pathologic Bone Resorption and Suppresses Osteoclastogenesis by Inducing A20 Expression.
    Lee MJ; Lim E; Mun S; Bae S; Murata K; Ivashkiv LB; Park-Min KH
    J Cell Physiol; 2016 Feb; 231(2):449-458. PubMed ID: 26189496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Lipopolysaccharide-Induced Inflammatory Bone Loss by Saikosaponin D is Associated with Regulation of the RANKL/RANK Pathway.
    Wu X; Zhao K; Fang X; Lu F; Zhang W; Song X; Chen L; Sun J; Chen H
    Drug Des Devel Ther; 2021; 15():4741-4757. PubMed ID: 34848946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.